Results 111 to 120 of about 5,803 (182)

Anti-HCV NS2-3 potential of selected plant bioactive compounds revealed by docking, simulation and DFT. [PDF]

Sci Rep
Mboto CI, Mbim EN, Edet UO, Lugos M, Abdalla M, Ndifon WO, Ebenso EE, Udo SI, Egharevba HO, George UE, El-Sayed MH, Abdalla SF.   +11 more
europepmc   +1 more source

Efficacy and safety of the sofosbuvir/ledipasvir treatment in chc-related decompensated cirrhosis and recurrent HCV infection after liver transplantation

, 2016
Amaç: Kronik hepatit C'ye (KHC) bağlı dekompanze sirotik ve karaciğer transplantasyonu sonrası hepatit C virüs (HCV) rekürrensi olan hastalarda etkin ve güvenli bir antiviral tedavi yaklaşımı sınırlı idi.
Erol, Cihan
core  

Long-term outcomes of patients with hepatitis C virus-related liver transplantation in a high-volume transplant center. [PDF]

BMC Gastroenterol
Ataman E, Harputluoglu M, Bilgic Y, Gözükara HG, Aladağ M, İnce V, Yılmaz S.   +6 more
europepmc   +1 more source

Identification of Candidate Inhibitors to SARS-CoV-2's Enzymes and Potential Disruptors of Its Structural Proteins' Interactions. [PDF]

Adv Biomed Res
Mohammadian A, Jadaliha M, Imanpour A, Pourvali Moghadam H, Jahangir A.   +4 more
europepmc   +1 more source

Efficacy and Safety of Direct-Acting Antivirals in Patients with Hepatitis C Infection: Nationwide Real-life Data from Türkiye. [PDF]

Turk J Gastroenterol
Gunduz A, Öztoprak NÇ, Sarı ND, Kurtaran B, Önlen Y, Senates E, Zerdali E, Karsen H, Batırel A, Ali RK, Güner R, Yamazhan T, Kose S, Erben N, Ince N, Köksal İ, Sarıgül Yıldırım F, Yoruk G, Komur S, Bal T, Kaya S, Esen Ş, Günal Ö, Yıldız IE, Inan D, Barut Ş, Namıduru M, Tosun S, Türker K, Sener A, Hızel K, Baykam N, Duygu F, Akıncı E, Can G, User U, Gül HC, Akbulut A, Çelebi G, Sünnetçioğlu M, Karabay O, Kumbasar Karaosmanoğlu H, Sırmatel F, Tabak F, Hep-C Turkey Study Group.   +44 more
europepmc   +1 more source

Unravelling HCV diversity and resistance in Viet Nam: a cross-sectional analysis. [PDF]

Lancet Reg Health West Pac
Le Ngoc C, Chai H, Airey G, Das T, Jennings D, Xu F, Flower B, Marjaneh MM, McCabe L, Le Manh H, Nguyen Van Vinh C, Trong TD, Ngoc TP, Thi Thu HV, Thwaites GE, van Doorn HR, Day J, Kestelyn E, Le Van T, Rahman M, Pett S, Barnes E, Walker AS, Cooke GS, Ansari MA.   +24 more
europepmc   +1 more source

Efficacy and safety of SOF/LDV in HCV-infected children and adolescents on hemodialysis: a prospective single-center observational study. [PDF]

Pediatr Nephrol
Enayet A, El-Karaksy H, Mogahed E, Yasin N, Ghita H, Ramadan Y.   +5 more
europepmc   +1 more source

Treatment of hepatitis C in children and adolescents: our experience to date, current status, and prospects. [PDF]

Clin Exp Hepatol
Pokorska-Śpiewak M, Talarek E, Aniszewska M, Dobrzeniecka A, Marczyńska MM.   +4 more
europepmc   +1 more source

A Box-Behnken design-assisted RP-HPLC method development and optimization for simultaneous determination of four antiviral drugs in pharmaceutical dosage forms. [PDF]

Sci Rep
Ghazy FH, El-Bagary RI, Fahim SH, Mahmoud ST.   +3 more
europepmc   +1 more source

Plasma proteome-wide Mendelian randomization reveals multi-ancestry drug targets for gastric cancer. [PDF]

Front Oncol
Zhi P, Cui Y, Xue G, Qiao L, Geng J, Chang Z, Xu Y, Yan J, Wang Y, Zhao C.   +9 more
europepmc   +1 more source